ETON Gunggung Aset Perusahaan Eton Pharma

Simbol resmi perusahaan Eton Pharmaceuticals Inc (ETON)

Eton Pharmaceuticals (ETON) maintains liquid medication production facilities without downtime due to planned order volumes. The business relies on the production of orphan drugs for children, where low competition ensures sustainable demand and stable profits. Simultaneously, the company is implementing eco-friendly packaging and safe waste disposal. Market price action demonstrates that total assets are reaching 108.74.

Eton Pharma - Total Aset Perusahaan ETON (periode 04.07.2022 - 31.10.2026)

Rincian metrik keuangan lan pasar Eton Pharma (ETON)

- kuotasi lan prakiraan analis:
Kurs saham etonpharma.com|ETON - Bagan rega target
- data kapitalisasi pasar:
Kapitalisasi pasar Eton Corp|ETON - Nilai Total Perusahaan
- data nilai buku modal saham:
Nilai Buku Saham Eton Pharmaceuticals|ETON - Kapitalisasi Buku|Koefisien Nilai Pasar marang Nilai Buku etonpharma.com|ETON - Total Aset Perusahaan
- rincian utang lan likuiditas:
Rasio Total Utang marang Ekuitas Eton Pharmaceuticals|ETON - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal Eton Corp|ETON - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Eton Corp|ETON - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Eton Pharmaceuticals|Koefisien jangkoan perantara etonpharma.com
- rincian asil keuangan lan kelipatan valuasi:
ETON - Penghasilan resik
Pambiji fundamental:Eton Pharmaceuticals
Barang utama Eton Pharmaceuticals

The total assets forecast for Eton Pharmaceuticals (ETON) reflects the overall value of resources and liabilities controlled by the enterprise. This indicator is calculated inversely via ROA, measuring the asset base to evaluate business scaling rates. Growth in this metric may indicate investments in robotics and AI models to accelerate the development of orphan drugs. The dynamics of this indicator allow investors to determine the efficiency of the company's capitalization of technological innovations.

Pesaing utama

Total Aset Bisnis VRTX|Aset Agregat Perusahaan Alnylam|Insmed Inc. (INSM) - Gunggung Aset Perusahaan|Aset Agregat Perusahaan United Therapeutics Corp. (UTHR)|BMRN: Nilai Total Aset Perusahaan|Total Aset Perusahaan BBIO (BridgeBio Pharma, Inc.)|BGM Group Limited (BGM) - Aset Perusahaan|Cogent Biosciences, Inc. - Total Aset Perusahaan|Xeris Biopharma Holdings, Inc. (XERS) - Gunggung Aset Perusahaan|KROS: Total Aset Perusahaan|ARCT - Gunggung Aset Perusahaan|KMDA (Kamada Ltd.) - Total Aset Perusahaan|Total Aset Perusahaan fulcrumtx.com|Aset Agregat Perusahaan Abeona Therapeutics (ABEO)|Aset Agregat Perusahaan MREO (mereobiopharma.com)|Total Aset Perusahaan PLX (Protalix)|Gunggung Aset Perusahaan Pliant Therapeutics Inc (PLRX)|APLT: Gunggung Aset Perusahaan|Nilai Total Aset Perusahaan RNTX|GELS: Total Aset Perusahaan|Aset Perusahaan Aytu BioPharma (AYTU)|CMMB (Chemomab Therapeutics Ltd) - Total Aset Perusahaan|Total Aset Bisnis SRXH (SRx Health)|Gunggung Aset Perusahaan PLRZ (Polyrizon Ltd)|AEZS (zentaris.com) - Nilai Agregat Aset|Aset Agregat Perusahaan Cyclo Therapeutics, Inc. CYTH|INZY (Inozyme Pharma Inc.) - Nilai Total Aset Perusahaan|Reneo Pharma - Total Aset Perusahaan|Nilai Agregat Aset CSCI (COSCIENS Bio)